South Korean drug regulator probes Roche over Tamiflu stockpiling
The Korea Food and Drug Administration launched an investigation into allegations that Roche Holding illegally helped multinational companies, including South Korean units of Novartis and HSBC, buy large batches of flu drug Tamiflu amid a surge in the number of H1N1 flu cases in the country. A spokeswoman for Roche said the company is "fully collaborating with the authorities."
Bloomberg
| 11/6
This story published in FDLI SmartBrief on 11/06/2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|